Imaging Clinical Research Scientist

Scorpion Therapeutics; Indianapolis (IN); On-site; USD 177,000 - 339,000; Full time

Job summary

Scorpion Therapeutics seeks a senior clinical development leader to drive diagnostic radiopharmaceutical programs across oncology, immunology, and cardiovascular disease.

You will define strategies, endpoints, patient populations, and imaging criteria while coordinating studies and regulatory documents with CROs, academia, and software partners. English fluency and 10–15% travel are required.

Qualifications

• PhD in a relevant field.
• 5+ years clinical development experience; 3+ years industry experience.
• GCP and regulatory familiarity.
• Fluency in written/spoken English. Travel 10–15%.

Responsibilities

• Lead integrated clinical development programs for diagnostic radiopharmaceuticals in oncology, immunology, and cardiovascular disease (early to late phase).
• Define clinical strategies, endpoints, patient populations, and imaging criteria.
• Design studies to assess diagnostic accuracy, imaging timing, biomarkers, and performance vs. standard-of-care.
• Serve as scientific expert in molecular imaging modalities (PET, SPECT, CT, MRI); oncology focus and theranostic applications a plus.
• Analyze/interpret imaging data and evaluate imaging biomarkers for stratification and monitoring.
• Collaborate with cross-functional internal teams and external partners (CROs, academia, software developers, scanner manufacturers).
• Author/review clinical and regulatory documents (IBs, protocols/amendments, CSRs, regulatory briefings).
• Communicate findings via presentations, abstracts, and publications.

Skills

Tracer development

Oncology focus

Immunology focus

Cardiology focus

GCP familiarity

Regulatory familiarity

Communication skills

Education

PhD in a relevant field

Job description

Key Responsibilities:

• Lead integrated clinical development programs for diagnostic radiopharmaceuticals in oncology, immunology, and cardiovascular disease (early to late phase).
• Define clinical strategies, endpoints, patient populations, and imaging criteria.
• Design studies to assess diagnostic accuracy, optimal imaging timing, patient selection biomarkers, and performance vs. standard-of-care.
• Serve as scientific expert in molecular imaging modalities (PET, SPECT, CT, MRI); oncology focus and emerging theranostic applications a plus.
• Analyze/interpret imaging data (tumor localization, tracer biodistribution, dosimetry, longitudinal response); evaluate imaging biomarkers for stratification and monitoring.
• Evaluate performance metrics (sensitivity, specificity, SUVs, tumor-to-background ratios).
• Guide development/validation/quantitative evaluation of advanced image analysis methods.
• Collaborate with cross-functional internal teams and external partners (CROs, academia, software developers, scanner manufacturers).
• Author/review clinical and regulatory documents (IBs, protocols/amendments, CSRs, regulatory briefings); develop imaging trial documentation.
• Communicate findings via presentations, abstracts, and publications.

Basic Requirements:

• PhD in a relevant field.
• 5+ years clinical development experience; 3+ years industry experience.

Additional Skills/Preferences:

• Tracer development; experience in oncology, immunology, and/or cardiology.
• Strong problem-solving and root-cause corrective action.
• GCP and regulatory familiarity.
• Ability to balance scientific and business priorities; strong communication/collaboration/organization/influence.
• Fluency in written/spoken English. Travel 10–15%.

Compensation/Benefits (if eligible):

• Anticipated wage: $177,000–$338,800; possible company bonus.
• Comprehensive benefits incl. 401(k), pension, vacation, medical/dental/vision/prescription, flexible spending, life/death benefits, time off/leave, and well-being benefits.